The January edition of the Webometrics world ranking, BETA version, has included 64 medical universities from Iran.
The 2nd International Congress on Artificial Intelligence in Medical Science (AIMS) is scheduled to be held in Tehran from ...
Intermittent fasting may benefit antioxidant and inflammatory markers in postmenopausal women with rheumatoid arthritis.
Department of Physiotherapy, Faculty of Rehabilitation, University of Tehran (Medical Sciences), Tehran, Iran Correspondence to Dr Hossein Bagheri, Department of Physiotherapy, Faculty of ...
1d
The Nation UAE on MSNKU, Iranian University sign MoU to collaborate in developing joint academic programsThe University of Karachi and Iranian University Shahed University inked a Memorandum of Understanding (MoU) to collaborate in developing joint academic programs. Prof Dr Iman Zamani and the KU Vice ...
The Patron-in-Chief of the conference will be SU acting Vice-Chancellor Prof. Dr. Khalil-ur-Rehman Khoumbati, while the ...
After the victory of the Islamic Revolution, Iranian women have made significant strides in the fields of science, education, ...
A revolutionary new treatment called Targeted Thermal Therapy (Tripel T) offers a safer, faster alternative to surgery for patients with high blood pressure caused by Primary Aldosteronism, a hormonal ...
1d
News Medical on MSNUVA launches trial to test AI-powered device for diabetes managementFor people living with Type 1 Diabetes (T1D), keeping blood sugar levels in check is a constant challenge. A new clinical trial at UVA is aiming to simplify diabetes management by testing an ...
Researchers at the University of Liège (Belgium) have uncovered a previously unknown mechanism that regulates the immune response against parasites. A small percentage of patients taking the ...
Trump gloats as Taylor Swift booed at Super Bowl and backs Elon Musk’s government cuts: Live - President mocks pop superstar ...
In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine (T-DM1) reduced the long-term risk of death or invasive disease by 46% and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results